Related Experiment Video
Updated: May 13, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
Published on: July 19, 2018
Are the Mesothelial-to-Mesenchymal Transition, Sclerotic Peritonitis Syndromes, and Encapsulating Peritoneal
Jesús Loureiro1, Guadalupe Gónzalez-Mateo, José Jimenez-Heffernan
1Centro de Biología Molecular Severo Ochoa, CSIC-UAM, Campus de Cantoblanco, Calle de Nicolás Cabrera 1, 28049 Madrid, Spain.
Abstract:
Mesothelial-to-mesenchymal transition (MMT) is an autoregulated physiological process of tissue repair that in uncontrolled conditions, such as peritoneal dialysis (PD), can lead to peritoneal fibrosis. The maximum expression of sclerotic peritoneal syndromes (SPS) is the encapsulating peritoneal sclerosis (EPS) for which no specific treatment exists. The SPS includes a wide range of peritoneal fibrosis that appears progressively and is considered as a reversible process, while EPS does not. EPS is a serious complication of PD characterized by a progressive intra-abdominal inflammatory process that results in bridles and severe fibrous tissue formation which cover and constrict the viscera. Recent studies show that transdifferentiated mesothelial cells isolated from the PD effluent correlate very well with the clinical events such as the number of hemoperitoneum and peritonitis, as well as with PD function (lower ultrafiltration and high Cr-MTC). In addition, in peritoneal biopsies from PD patients, the MMT correlates very well with anatomical changes (fibrosis and angiogenesis). However, the pathway to reach EPS from SPS has not been fully and completely established. Herein, we present important evidence pointing to the MMT that is present in the initial peritoneal fibrosis stages and it is perpetual over time, with at least theoretical possibility that MMT initiated the fibrosing process to reach EPS.
Insights
Mesothelial-to-mesenchymal transition (MMT) drives peritoneal fibrosis in peritoneal dialysis (PD). This process, potentially initiating encapsulating peritoneal sclerosis (EPS), highlights MMT
Area of Science:
- Nephrology
- Cell Biology
- Pathology
Background:
- Mesothelial-to-mesenchymal transition (MMT) is crucial for tissue repair but can cause peritoneal fibrosis under conditions like peritoneal dialysis (PD).
- Sclerotic peritoneal syndromes (SPS), including encapsulating peritoneal sclerosis (EPS), represent severe peritoneal fibrosis, with EPS being an irreversible complication of PD.
- The exact pathway from initial fibrosis to advanced EPS remains unclear.
Purpose of the Study:
- To investigate the role of MMT in the progression of peritoneal fibrosis from SPS to EPS.
- To establish the link between MMT and the development of irreversible peritoneal damage in PD patients.
Main Methods:
- Analysis of transdifferentiated mesothelial cells in PD effluent.
- Examination of peritoneal biopsies from PD patients.
- Correlation of MMT markers with clinical events and anatomical changes.
Main Results:
- Transdifferentiated mesothelial cells in PD effluent correlate with clinical events (hemoperitoneum, peritonitis) and PD function.
- MMT in peritoneal biopsies correlates with fibrosis and angiogenesis.
- Evidence suggests MMT is present early in fibrosis and persists, potentially initiating the fibrotic process leading to EPS.
Conclusions:
- MMT is a persistent process present from early stages of peritoneal fibrosis.
- MMT is implicated as a potential initiator of the fibrotic cascade leading to severe complications like EPS in PD patients.
- Further research is needed to fully elucidate the MMT pathway in EPS pathogenesis.
Related Concept Videos
Ascites
Cirrhosis II: Pathophysiology
Pleural Disorders: Types and Brief Description
Cellular Adaptation IV: Dysplasia and Metaplasia
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Peritoneum
Anatomy of the Peritoneum
The peritoneum is divided into two layers: the parietal peritoneum and the visceral...
